Pricing Log in Create free account

Invivyd, Inc. (IVVD) vs Cartesian Therapeutics, Inc. (RNAC)

Invivyd, Inc. and Cartesian Therapeutics, Inc. are both Biotechnology companies. Invivyd, Inc. and Cartesian Therapeutics, Inc. are of similar size ($191.8M and $190.4M). Invivyd, Inc. grew revenue faster over the last twelve months: 26.3% against −94.8%. Cartesian Therapeutics, Inc. has the higher net margin (0.00% vs −183.9%) and the higher return on invested capital (0.00% vs −334.9%). Across the 16 metrics below, Cartesian Therapeutics, Inc. leads on 11 and Invivyd, Inc. on 5.

Valuation

Metric IVVD RNAC Biotechnology median
P/E n/m n/m 8.42
P/S 3.68 109.24 10.01
P/B 1.19 n/m 2.21
Price to free cash flow n/m n/m 21.01
EV/EBITDA n/m n/m 0.61
EV/Sales 0.94 61.62 9.41
Earnings yield (49.25%) (90.12%) (31.85%)
Free cash flow yield (51.08%) (40.54%) (24.58%)

Profitability

Metric IVVD RNAC Biotechnology median
Gross margin 92.23% 100.00% 65.16%
Operating margin (192.81%) 0.00% 0.00%
Net margin (183.90%) 0.00% 0.00%
Free cash flow margin (187.88%) 0.00% 0.00%
Return on equity (95.89%) 236.88% (56.36%)
Return on assets (69.69%) (42.77%) (48.04%)
Return on invested capital (334.92%) 0.00% 0.00%

Growth

Metric IVVD RNAC Biotechnology median
Revenue growth (TTM) 26.30% (94.81%) 6.02%
EPS growth (last fiscal year) 79.02% (11.80%) 30.26%
Revenue growth, 5-year CAGR — (29.96%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IVVD RNAC Biotechnology median
Debt to equity 0.00 (0.42) 0.00
Current ratio 5.87 7.48 4.72
Net debt to EBITDA 4.24 0.89 0.96

Dividend

Metric IVVD RNAC Biotechnology median
Dividend yield — — 0.08%
Payout ratio — — —

Size

Metric IVVD RNAC Biotechnology median
Market cap 190.41m 191.82m 132.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack